Advertisement
ProteinSimple
ProteinSimple

News Analysis

Most Recent

Patent knowledge

By | November 20, 2000

A special report just published in the UK reveals the extent and pace of the gene patent rush.

0 Comments

Nearly a million children die each year of malaria, but the parasite became resistant to the cheapest drug. Now we know why.

0 Comments

Modifying genetic research

By | November 15, 2000

GM food has provoked much protest but GM medicine has more public approval: the difference lies in approaches to research.

0 Comments

Many drugs effective against tropical diseases are no longer available or in danger of being pulled from the market because they are unprofitable.

0 Comments

Ritalin gets vote of approval in the UK

By | November 9, 2000

A new UK directive supports use of the controversial drug Ritalin in severe Attention Deficit/Hyperactivity Disorder (ADHD), but only under specialist supervision.

0 Comments

A game of monopoly

By | November 8, 2000

Reed Elsevier's proposed takeover of Harcourt has provoked an outcry from librarians and academics alike - but do they have the muscle to influence it?

0 Comments

Therapeutic cloning endorsed by Royal Society

By | November 8, 2000

The UK's Royal Society yesterday released a report backing continued research into the use of cloned embryonic stem cells.

0 Comments

HOUSTON. Amgen, the largest biotechnology company in the world, is funding research focusing on disorders that destroy parts of the nervous system. These include Alzheimer's disease, Parkinson's disease, multiple sclerosis and stroke. Medicines for disorders resulting from dysfunction of the neuroendocrine system such as obesity and Type 2 diabetes are also under development. In both areas, Amgen licenses product candidates and technologies that complement its internal drug discovery and develop

0 Comments

New companies to commercialise neuroscience discoveries

By | November 3, 2000

Neurogenomics has significant commercial potential by way of gene targets for enhancement of brain function and treatment of brain-based disease.

0 Comments

Senior scientists promise to boycott journals

By | November 2, 2000

Leading scientists will refuse to publish, edit or subscribe to journals that do not make research articles available free of charge.

0 Comments

Advertisement

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  3. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

  4. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

Advertisement
Advertisement
Life Technologies